Press release 📈 Stocks 🌍 Ireland

Neuromod Devices Appoints Joe Ghiz as Chief Commercial Officer

Neuromod Devices names former Align Technology executive Joe Ghiz as Chief Commercial Officer to drive global expansion for its tinnitus treatment device, Lenire.

📅 October 1, 2026 🕐 1 min read

2 assets impacted. Net bias: 0 Bullish, 0 Bearish, 2 Neutral. Strongest signal: NMD → 3/10 (60% confidence).

📊 Affected Assets (2)

NMD

Neutral 🤖 60%

📅 Short-term 🌍 IE · Explicit

Appointment of a new Chief Commercial Officer is a routine corporate development with no immediate financial impact.

ALGN

Neutral 🤖 65%

📅 Short-term 🌍 US · Explicit

Mentioned as the previous employer of the new CCO, not directly affected by the announcement.

🎯 Key Takeaways

Joe Ghiz joins Neuromod Devices to lead global commercial strategy.
The appointment focuses on expanding access to the Lenire tinnitus treatment device.
Ghiz brings extensive industry experience from his previous senior roles at Align Technology.

📝 Executive Summary

Neuromod Devices has appointed Joe Ghiz as its new Chief Commercial Officer to spearhead global commercial strategy for its Lenire tinnitus treatment device. Ghiz joins the firm following a tenure in senior global leadership roles at Align Technology.

❓ FAQ

What is the primary focus of Joe Ghiz's new role at Neuromod?

As Chief Commercial Officer, Joe Ghiz will lead the company's global commercial strategy and oversee the expansion of access to the Lenire tinnitus treatment device.

📰 Related Articles

🏷️ Tags

📰 Source

🔗 View Original Article